Clamp group (n = 22) | Control group (n = 25) | P value | |
---|---|---|---|
Bleeding in labor (n = 27) | (n = 12) | (n = 15) | |
Intrapartum blood loss (g), mean (SD) | 656.2±72.79 | 811.8±86.07 | .001a |
Bleeding in the ward (n = 20) | (n = 10) | (n = 10) | |
Blood loss in 30 min (g), mean (SD) | 42.8±6.60 | 126.3±86.97 | .007a |
Blood loss in 30~60 min (g), mean (SD) | 10.4±1.96 | 21.88±2.30 | .000a |
Hemoglobin (g/L),mean (SD) | |||
Preoperative Hb | 119±4.10 | 121.4±4.19 | .058 |
Postoperative Hb | 96.9±8.33 | 96.1±7.39 | .718 |
Blood transfusion, n(%) | 2 (9.1%) | 3 (12%) | .746 |
Repeated usage of uterotonic, n(%) | .001a | ||
≤2 (type/time) | 18 (81.8%) | 9 (36%) | |
≥3 (type/time) | 4 (18.2%) | 16 (64%) | |
Uterotonic side effect, n(%) | 4 (18.2%) | 12 (48%) | .031a |
Clamp complications, n(%) | 0 | – | |
Surgical procedures, n(%) | |||
Intrauterine Bakri balloon | 1 (4.5%) | 3 (12%) | .36a |
Urgent UAE | 1 (4.5%) | 1 (4.0%) | .93a |
Laparotomy | 0 | 0 | – |
Hospital stay (days), mean (SD) | 4.1±1.57 | 3.8±1.61 | .535 |